a decreasing trendp < 0.01
After the implementation of the NVBP policy, the continuously increasing trend of the average monthly per-visit expenditure of chemotherapy drugs ( p < 0.01), oral endocrine drugs ( p < 0.01) and TCM ( p < 0.01) has been effectively mitigated; in particular, the average monthly per-visit expenditure of TCM has been changed from an increasing trend to a decreasing trend with 12.22 CNY ( p < 0.01) per month.